FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
This is a discussion on FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury within the FDA News forum, part of the Industry News and Updates category; More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-26-2010, 11:40 AM
|
|||
|
|||
FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil | industry_news | FDA News | 0 | 04-21-2010 01:06 PM |
| FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development | industry_news | FDA News | 0 | 03-31-2010 01:28 PM |
| FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea | industry_news | FDA News | 0 | 02-23-2010 11:59 AM |
| Early Communication about an Ongoing Safety Review Orlistat (marketed as Alli and Xenical) | industry_news | FDA News | 0 | 08-24-2009 02:58 PM |
© 2008 DrugManagementForum™ powered by |
 |